HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nutraceuticals International Spurns NAD Review

This article was originally published in The Tan Sheet

Executive Summary

Nutraceuticals International says it will answer questions FDA and the Federal Trade Commission may have rather than participate in the National Advertising Division's review of advertising claims for its FucoPure supplement ingredient

You may also be interested in...

NAD reviews Colotox

The National Advertising Division gives Central Coast Nutraceuticals a second chance to participate in the self-regulatory review process for claims about the firm's Colotox dietary supplement. The Council of Better Business Bureaus' division referred the company to FDA and the Federal Trade Commission in February after the firm failed to respond to NAD's query (1"The Tans Sheet" Feb. 16, 2009, p. 19). Following the referral the advertiser contacted NAD, which reopened the case (2"The Tan Sheet" April 13, 2009, p. 15). NAD says June 3 it determined Central Coast supported claims that Colotox's laxative properties "decrease gas and bloating," "reduce water retention" and relieve constipation. The Phoenix-based firm also supported claims that Colotox increased energy and relieved chronic fatigue. It did not sufficiently support weight-loss claims or claims Colotox removes toxic build-up. The firm says it does not agree with NAD's recommendation to discontinue detoxification claims, but will comply

NAD Refers Central Coast Nutraceuticals’ Colotox Ads To FTC And FDA

The National Advertising Division will refer Central Coast Nutraceuticals' Colotox advertising to the Federal Trade Commission and FDA for review after the firm failed to respond to an inquiry

FTC Fines Oreganol Marketer $2.5 Million After Firm Ignores NAD Inquiry

North American Herb & Spice Co. has agreed to pay a $2.5 million fine to settle a complaint the Federal Trade Commission filed after the firm failed to respond to an inquiry from the National Advertising Division


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts